VedaBio Accelerating Amplification-Free Syndromic POC MDx With Additional CRISPR IP

VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology

The Microbiome May Hold the Key to IVF Success

Matterworks Inc. Secures Series A Funding to Advance to Advance Machine Intelligence for Predictive Biology

Manus and Inscripta merge to create a leader in industrial biomanufacturing

Freya: Restoring microbial balance in the reproductive tract

VedaBio Appoints Rachel Jones as Chief Commercial Officer

Delix Presents Full Results from Phase 1 Trial of DLX-001 at ACNP Annual Meeting

Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting

Constructive Bio Secures $58 Million in Series A Financing

Mythic Therapeutics to Present Data from Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting

Lightcast Opens Innovation Center in United States to Support Global Expansion of Luminary Early Access Program